New Oxazolo[5,4-d]pyrimidines as Potential Anticancer Agents: Their Design, Synthesis, and In Vitro Biological Activity Research
出版年份 2022 全文链接
标题
New Oxazolo[5,4-d]pyrimidines as Potential Anticancer Agents: Their Design, Synthesis, and In Vitro Biological Activity Research
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 19, Pages 11694
出版商
MDPI AG
发表日期
2022-10-09
DOI
10.3390/ijms231911694
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- FDA-Approved Small Molecule Compounds as Drugs for Solid Cancers from Early 2011 to the End of 2021
- (2022) Aleksandra Sochacka-Ćwikła et al. MOLECULES
- Novel antiproliferative agents bearing substituted thieno[2,3-d]pyrimidine scaffold as dual VEGFR-2 and BRAF kinases inhibitors and apoptosis inducers; design, synthesis and molecular docking
- (2022) Rasha A. Hassan et al. BIOORGANIC CHEMISTRY
- Peptidyl-Resin Substrates as a Tool in the Analysis of Caspase Activity
- (2022) Remigiusz Bąchor MOLECULES
- The Synergistic Cytotoxic Effects of GW5074 and Sorafenib by Impacting Mitochondrial Functions in Human Colorectal Cancer Cell Lines
- (2022) Je-Ming Hu et al. Frontiers in Oncology
- Exploration of structural requirements for the inhibition of VEGFR-2 tyrosine kinase: Binding site analysis of type II, ‘DFG-out’ inhibitors
- (2021) Siddharth J. Modi et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Facile one-pot sequential synthesis of novel diaryl urea derivatives and evaluation of their in vitro cytotoxicity on adenocarcinoma cells
- (2021) Fereshteh Azimian et al. MEDICINAL CHEMISTRY RESEARCH
- Synthesis and Rational Design of New Appended 1,2,3-Triazole-uracil Ensembles as Promising Anti-Tumor Agents via In Silico VEGFR-2 Transferase Inhibition
- (2021) Nadipolla Naresh Reddy et al. MOLECULES
- ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties
- (2021) Guoli Xiong et al. NUCLEIC ACIDS RESEARCH
- Synthesis, Physicochemical Characteristics and Plausible Mechanism of Action of an Immunosuppressive Isoxazolo[5,4-e]-1,2,4-Triazepine Derivative (RM33)
- (2021) Marcin Mączyński et al. Pharmaceuticals
- Synthesis and biological evaluation of novel ligustrazine-chalcone derivatives as potential anti-triple negative breast cancer agents
- (2021) Yingqi Luo et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- FDA-Approved Drugs for Hematological Malignancies—The Last Decade Review
- (2021) Aleksandra Sochacka-Ćwikła et al. Cancers
- LigRMSD: a web server for automatic structure matching and RMSD calculations among identical and similar compounds in protein-ligand docking
- (2020) José Luis Velázquez-Libera et al. BIOINFORMATICS
- Synthesis and anticancer activity of new tetrahydroquinoline hybrid derivatives tethered to isoxazoline moiety
- (2020) Cristian C. Bernal et al. MEDICINAL CHEMISTRY RESEARCH
- Synthesis of novel isoxazole functionalized pyrazolo[3,4‐ b ]pyridine derivatives; their anticancer activity
- (2020) Sampath Ravula et al. JOURNAL OF HETEROCYCLIC CHEMISTRY
- New series of isoxazole derivatives targeting EGFR-TK: Synthesis, molecular modeling and antitumor evaluation
- (2020) Eman T. Warda et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis and Biological Activity of New 7-Amino-oxazolo[5,4-d]Pyrimidine Derivatives
- (2020) Aleksandra Sochacka-Ćwikła et al. MOLECULES
- Synthesis, In silico and In vitro Evaluation of Novel Oxazolopyrimidines as Promising Anticancer Agents
- (2020) Steven Patrick Nolan et al. HELVETICA CHIMICA ACTA
- Anticancer Strategy Targeting Cell Death Regulators: Switching the Mechanism of Anticancer Floxuridine-Induced Cell Death from Necrosis to Apoptosis
- (2020) Akira Sato et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pro‑apoptotic activity of novel synthetic isoxazole derivatives exhibiting inhibitory activity against tumor cell growth in vitro
- (2020) Ilaria Lampronti et al. Oncology Letters
- Discovery of 4-((4-(4-(3-(2-(2,6-difluorophenyl)-4-oxothiazolidin-3-yl)ureido)-2-fluorophenoxy)-6-methoxyquinolin-7-yl)oxy)-N,N-diethylpiperidine-1-carboxamide as kinase inhibitor for the treatment of colorectal cancer
- (2020) Yuting Zhou et al. BIOORGANIC CHEMISTRY
- Molecular Bases of VEGFR-2-Mediated Physiological Function and Pathological Role
- (2020) Xinrong Wang et al. Frontiers in Cell and Developmental Biology
- Synthesis, immunosuppressive properties, mechanism of action and X-ray analysis of a new class of isoxazole derivatives
- (2019) Urszula Bąchor et al. ACTA POLONIAE PHARMACEUTICA
- Pyrazolo-benzothiazole hybrids: Synthesis, anticancer properties and evaluation of antiangiogenic activity using in vitro VEGFR-2 kinase and in vivo transgenic zebrafish model
- (2019) Velma Ganga Reddy et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Novel Pazopanib-Based HDAC and VEGFR Dual Inhibitors Targeting Cancer Epigenetics and Angiogenesis Simultaneously
- (2018) Jie Zang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and cellular bioactivities of novel isoxazole derivatives incorporating an arylpiperazine moiety as anticancer agents
- (2018) Burcu Çalışkan et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Synthesis, biological evaluation, molecular docking and DFT calculations of novel benzenesulfonamide derivatives
- (2018) Asmaa M. Fahim et al. JOURNAL OF MOLECULAR STRUCTURE
- Discovery of N-(4-((7-(3-(4-ethylpiperazin-1-yl)propoxy)-6-methoxyquinolin-4-yl)oxy)-3,5-difluorophenyl)-N-(2-(2,6-difluorophenyl)-4-oxothiazolidin-3-yl)urea as a multi-tyrosine kinase inhibitor for drug-sensitive and drug-resistant cancers treatment
- (2018) Baohui Qi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer
- (2017) Valentina Belli et al. Oncotarget
- Synergistic inhibition of sunitinib and ethaselen against human colorectal cancer cells proliferation
- (2016) Xiaoqing Zheng et al. BIOMEDICINE & PHARMACOTHERAPY
- Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors
- (2016) Mauro Di Matteo et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis, Molecular Modeling and Biological Evaluation of 4-Alkoxyquinazoline Derivatives as Novel Inhibitors of VEGFR2
- (2016) Liang Lu et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- Synthesis, biological evaluation, and molecular docking studies of new pyrazol-3-one derivatives with aromatase inhibition activities
- (2016) Xue-Jing Yi et al. Chemical Biology & Drug Design
- Diarylureas and Diarylamides with Oxazolo[5,4-d]pyrimidine Scaffold as Angiogenesis Inhibitors
- (2016) Ya-Hui Deng et al. CHEMISTRY & BIODIVERSITY
- Synthesis of new secretory phospholipase A 2 -inhibitory indole containing isoxazole derivatives as anti-inflammatory and anticancer agents
- (2016) Srinivasa Rao Pedada et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Influence of 5-amino-3-methyl-4-isoxazolecarbohydrazide on selective gene expression in Caco-2 cultured cells
- (2016) Paulina Płoszaj et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Design, Synthesis and Biological Evaluation of Stilbene Derivatives as Novel Inhibitors of Protein Tyrosine Phosphatase 1B
- (2016) Haibing He et al. MOLECULES
- 5-Hydroxy-7-azaindolin-2-one, a novel hybrid of pyridinol and sunitinib: design, synthesis and cytotoxicity against cancer cells
- (2016) Sajita Shah et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Potent anti-angiogenic and cytotoxic effect of conferone on human colorectal adenocarcinoma HT-29 cells
- (2016) Omid Cheraghi et al. PHYTOMEDICINE
- Evaluation of P-Glycoprotein Inhibitory Potential Using a Rhodamine 123 Accumulation Assay
- (2016) Elodie Jouan et al. Pharmaceutics
- Mitochondrial apoptosis: killing cancer using the enemy within
- (2015) J Lopez et al. BRITISH JOURNAL OF CANCER
- Synthesis and Biological Evaluation of Novel Oxazolo[5,4-d]pyrimidines as Potent VEGFR-2 Inhibitors
- (2015) Ya-Hui Deng et al. CHEMISTRY & BIODIVERSITY
- Discovery of 4-arylamido 3-methyl isoxazole derivatives as novel FMS kinase inhibitors
- (2015) Daseul Im et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The effect of 5-amino-3-methyl-4-isoxazolecarboxylic acid hydrazide on lymphocyte subsets and humoral immune response in SRBC-immunized mice
- (2015) Angelika Drynda et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- CPU-12, a novel synthesized oxazolo[5,4-d]pyrimidine derivative, showed superior anti-angiogenic activity
- (2015) Jiping Liu et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Pazopanib diminishes non-small cell lung cancer (NSCLC) growth and metastases in vivo
- (2015) Honglin Zhao et al. Thoracic Cancer
- Artesunate overcomes drug resistance in multiple myeloma by inducing mitochondrial stress and non-caspase apoptosis
- (2015) Xenofon Papanikolaou et al. Oncotarget
- Discovery of potent N-(isoxazol-5-yl)amides as HSP90 inhibitors
- (2014) Danqi Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- In vitroimmunomodulatory effects of 5-amino-3-methyl-4-isoxazolecarboxylic acid hydrazide on the cellular immune response
- (2014) Angelika Drynda et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Restoration of immune system function is accelerated in immunocompromised mice by the B-cell-tropic isoxazole R-11
- (2014) Michał Zimecki et al. Pharmacological Reports
- E7080 (Lenvatinib), a Multi-Targeted Tyrosine Kinase Inhibitor, Demonstrates Antitumor Activities Against Colorectal Cancer Xenografts
- (2014) Armin Wiegering et al. NEOPLASIA
- Antitumor activities of the targeted multi-tyrosine kinase inhibitor lenvatinib (E7080) against RET gene fusion-driven tumor models
- (2013) Kiyoshi Okamoto et al. CANCER LETTERS
- Selective VEGFR Inhibitors for Anticancer Therapeutics in Clinical Use and Clinical Trials
- (2012) Cunlong Zhang et al. CURRENT PHARMACEUTICAL DESIGN
- Isoxazolo(aza)naphthoquinones: A new class of cytotoxic Hsp90 inhibitors
- (2012) Alberto Bargiotti et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors
- (2012) M. McTigue et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The B-Raf Status of Tumor Cells May Be a Significant Determinant of Both Antitumor and Anti-Angiogenic Effects of Pazopanib in Xenograft Tumor Models
- (2011) Brunilde Gril et al. PLoS One
- Design and synthesis of novel isoxazole-based HDAC inhibitors
- (2010) Paola Conti et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- ZD6474 enhances paclitaxel antiproliferative and apoptotic effects in breast carcinoma cells
- (2010) Siddik Sarkar et al. JOURNAL OF CELLULAR PHYSIOLOGY
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
- (2009) Garrett M. Morris et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- NVP-AUY922: A Novel Heat Shock Protein 90 Inhibitor Active against Xenograft Tumor Growth, Angiogenesis, and Metastasis
- (2008) S. A. Eccles et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started